Human Molecular Genetics Advance Access published online on February 6, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl017
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medical Biotechnology Center, Program in Neurodegenerative Diseases
* To whom correspondence should be addressed. Expanded polyglutamine tracts are associated with the induction of protein aggregation and cause cytotoxicity in nine different neurodegenerative disorders. Here, we report that ubiquilin suppresses polyglutamine-induced protein aggregation and toxicity in cells and in an animal model of Huntington's disease. Overexpression of ubiquilin in HeLa cells and primary neurons reduced aggregation of polyglutamine-containing proteins and cell death induced by overexpression of a GFP-Huntingtin-fusion protein containing 74 polyglutamine repeats (GFP-Htt(Q74)), in a dose-dependent manner. Moreover, overexpression of ubiquilin suppressed oxidative stress-induced cell death in HeLa cell lines stably expressing GFP-Htt(Q74). By contrast, knockdown of ubiquilin expression in these cell lines was associated with increases in DNA fragmentation, caspase activation, GFP-fusion protein aggregation, and cell death. Caenorhabditis elegans (C. elegans) lines expressing GFP-Htt-fusion proteins in body wall muscle displayed a polyglutamine repeat length-dependent decrease in body movement compared to wild-type animals. RNA interference of the C. elegans ubiquilin gene exacerbated the motility defect, whereas overexpression of ubiquilin prevented, and could rescue, loss of worm movement induced by overexpression of GFP-Htt(Q55). These results suggest that ubiquilin might be a novel therapeutic target for treating polyglutamine diseases.
Received December 23, 2005
Revised February 2, 2006
Accepted February 2, 2006
Article
Suppression of Polyglutamine-Induced Toxicity in Cell and Animal Models of Huntington's Disease by Ubiquilin
Hongmin Wang 1,
Precious J. Lim 2,
Chaobo Yin 1,
Matthias Rieckher 1,
Bruce E. Vogel 2,
and
Mervyn J. Monteiro 3 *
2 Medical Biotechnology Center, Program in Neurodegenerative Diseases; Program in Molecular Medicine, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, Maryland 21201
3 Medical Biotechnology Center, Program in Neurodegenerative Diseases, Institute for Neurodegenerative Diseases, Room N352; Program in Molecular Medicine, University of Maryland Biotechnology Institute, 725 West Lombard Street, Baltimore, Maryland 21201
Mervyn J. Monteiro, E-mail: monteiro{at}umbi.umd.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Lim, R. Danner, J. Liang, H. Doong, C. Harman, D. Srinivasan, C. Rothenberg, H. Wang, Y. Ye, S. Fang, et al. Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD J. Cell Biol., October 19, 2009; 187(2): 201 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caccamo, S. Majumder, J. J. Deng, Y. Bai, F. B. Thornton, and S. Oddo Rapamycin Rescues TDP-43 Mislocalization and the Associated Low Molecular Mass Neurofilament Instability J. Biol. Chem., October 2, 2009; 284(40): 27416 - 27424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, Y. Shi, K. A. Hanson, L. M. Williams, R. Sakasai, M. J. Bowler, and R. S. Tibbetts Potentiation of Amyotrophic Lateral Sclerosis (ALS)-associated TDP-43 Aggregation by the Proteasome-targeting Factor, Ubiquilin 1 J. Biol. Chem., March 20, 2009; 284(12): 8083 - 8092. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, P. J. Lim, M. Karbowski, and M. J. Monteiro Effects of overexpression of Huntingtin proteins on mitochondrial integrity Hum. Mol. Genet., February 15, 2009; 18(4): 737 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. K. Leung, P. L. Williams, A. Benedetto, C. Au, K. J. Helmcke, M. Aschner, and J. N. Meyer Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology Toxicol. Sci., November 1, 2008; 106(1): 5 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Ponce de Leon, L. Golovanova, V. Doronichev, G. Romanova, T. Akazawa, O. Kondo, H. Ishida, and C. P. E. Zollikofer From the Cover: Neanderthal brain size at birth provides insights into the evolution of human life history PNAS, September 16, 2008; 105(37): 13764 - 13768. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Raychaudhuri, M. Sinha, D. Mukhopadhyay, and N. P. Bhattacharyya HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity Hum. Mol. Genet., January 15, 2008; 17(2): 240 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ganguly, R.M. R. Feldman, and M. Guo ubiquilin antagonizes presenilin and promotes neurodegeneration in Drosophila Hum. Mol. Genet., January 15, 2008; 17(2): 293 - 302. [Abstract] [Full Text] [PDF] |
||||




